These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12796540)

  • 41. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial.
    Özkan M; Kalçık M; Gürsoy MO; Öcal L; Griffini S; Karakoyun S; Yesin M; Gündüz S; Astarcıoğlu MA; Bayam E; Cerşit S; Aykan AÇ; Cugno M
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intracardiac thrombus formation with rapidly progressive heart failure in the neonate: treatment with tissue type plasminogen activator.
    Van Overmeire B; Van Reempts PJ; Van Acker KJ
    Arch Dis Child; 1992 Apr; 67(4 Spec No):443-5. PubMed ID: 1586189
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salvage of a congested DIEAP flap with subcutaneous recombinant tissue plasminogen activator treatment.
    Ayhan S; Uygur S; Kucukoduk I; Sencan A
    J Plast Reconstr Aesthet Surg; 2009 Nov; 62(11):e453-4. PubMed ID: 18851936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions.
    Shi ZS; Loh Y; Walker G; Duckwiler GR;
    Stroke; 2010 Jun; 41(6):1185-92. PubMed ID: 20431084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hyperdense areal in the putamen after intra-arterial medialysis: contrast media extravasation or hemorrhage?].
    Möller-Hartmann W; Krings T; Mull M
    Rofo; 2002 Apr; 174(4):497-8. PubMed ID: 11960417
    [No Abstract]   [Full Text] [Related]  

  • 46. The evolution of the Helsinki frostbite management protocol.
    Lindford A; Valtonen J; Hult M; Kavola H; Lappalainen K; Lassila R; Aho P; Vuola J
    Burns; 2017 Nov; 43(7):1455-1463. PubMed ID: 28778759
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model.
    Phillips DA; Fisher M; Smith TW; Davis MA
    Ann Neurol; 1988 Apr; 23(4):391-4. PubMed ID: 3132892
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant tissue plasminogen activator in the treatment of central venous catheter occlusion in children.
    Jacobs BR; Haygood M; Hingl J
    J Pediatr; 2001 Oct; 139(4):593-6. PubMed ID: 11598611
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombolysis of a neonatal brachial artery thrombosis with tissue plasminogen activator.
    Grieg A
    J Perinatol; 1998; 18(6 Pt 1):460-2. PubMed ID: 9848761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Massive endocardial thrombosis in a patient with a peritoneo-jugular shunt for refractory ascites: the therapeutic success of tissue plasminogen activator and defibrotide].
    Sacchetti C; Pederzoli S; Tamborrino E; Grandi M
    Recenti Prog Med; 1994; 85(7-8):387-90. PubMed ID: 8079040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.
    Papadopoulos SM; Chandler WF; Salamat MS; Topol EJ; Sackellares JC
    J Neurosurg; 1987 Sep; 67(3):394-8. PubMed ID: 3112328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transarterial fibrinolysis using tissue plasminogen activator in a patient with acute renal failure due to acute thrombosis of bilateral renal arteries. 3 years' follow-up.
    Takeda M; Katayama Y; Takahashi H; Saito K; Tsutsui T; Komeyama T; Sato S
    Nephron; 1994; 66(2):240-1. PubMed ID: 8139751
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment with rtPA of stroke associated with intravenous immunoglobulins perfusion.
    Fonseca AC; Geraldes R; Almeida V; Pinho e Melo T
    J Neurol Sci; 2011 Sep; 308(1-2):180-1. PubMed ID: 21665226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safe Readministration of Intravenous Thrombolysis in Recurrent Basilar Thrombosis.
    Khan A; Itrat A
    J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):e48-e49. PubMed ID: 29100857
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of thrombosis relapse in antiphospholipid syndrome patients refractory to conventional therapy using intravenous immunoglobulin.
    Sciascia S; Giachino O; Roccatello D
    Clin Exp Rheumatol; 2012; 30(3):409-13. PubMed ID: 22513222
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study.
    Mazighi M; Serfaty JM; Labreuche J; Laissy JP; Meseguer E; Lavallée PC; Cabrejo L; Slaoui T; Guidoux C; Lapergue B; Klein IF; Olivot JM; Abboud H; Simon O; Niclot P; Nifle C; Touboul PJ; Raphaeli G; Gohin C; Claeys ES; Amarenco P;
    Lancet Neurol; 2009 Sep; 8(9):802-9. PubMed ID: 19647488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of recombinant tissue-type plasminogen activator in a newborn with an intracardiac thrombus developed during extracorporeal membrane oxygenation.
    Garcia A; Gander JW; Gross ER; Reichstein A; Sheth SS; Stolar CJ; Middlesworth W
    J Pediatr Surg; 2011 Oct; 46(10):2021-4. PubMed ID: 22008344
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Successful Rescue Utilization of Intraoperative Tissue Plasminogen Activator in the Setting of Massive Thrombosis of Avalon Catheter and Patient in Extremis with Refractory Hypoxemia.
    Martin AK; Allen WL; Fritz AV; Diaz-Gomez JL
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2278-2281. PubMed ID: 29395819
    [No Abstract]   [Full Text] [Related]  

  • 60. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
    Niessen F; Hilger T; Hoehn M; Hossmann KA
    Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.